Science & Enterprise subscription

Follow us on Twitter

  • A company developing health metrics with artificial intelligence received a grant to better understand polycystic o… https://t.co/ElPrTv6NfS
    about 11 hours ago
  • New post on Science and Enterprise: Small Biz Grant Funds AI Repro Health Technology https://t.co/kf8kmvP8Xa #Science #Business
    about 11 hours ago
  • The Food and Drug Administration began a pilot program for assessing alternative technologies to test drugs, biolog… https://t.co/r5mRCGGL4B
    about 16 hours ago
  • New post on Science and Enterprise: FDA Begins Qualifying Non-Animal Testing Options https://t.co/pf0GN32FfV #Science #Business
    about 16 hours ago
  • A new enterprise is developing personalized digital therapeutics for people with Alzheimer's disease and other neur… https://t.co/aFxlnK5VHH
    about 1 day ago

Please share Science & Enterprise

University, Company to Collaborate on Cancer Imaging

Hugh Cormican (QUBIS Ltd.)

Hugh Cormican (QUBIS Ltd.)

Queen’s University in Belfast, Northern Ireland, U.K., is partnering with start-up company Cirdan Imaging Ltd., also in Northern Ireleand, to develop new imaging tools for the detection and treatment of cancer. As part of the deal, QUBIS Ltd., the university’s technology transfer subsidiary, will take an equity stake in Cirdan Imaging.

The agreement involves research to develop imaging equipment using X-rays and near-infrared fluorescence to help in the detection, diagnosis, and treatment of cancer. The new devices will be used to better discriminate between healthy and malignant tissue in diagnostic procedures and cancer surgery.

Cirdan is developing its first new device, an imaging tool to help radiologists to take a biopsy from a suspect lesion to help diagnose breast cancer.  The company says it expects to launch the product in the next 12 months.

“We know that speed of detection and treatment of cancer is critical to patient outcomes,” says Hugh Cormican, CEO of Cirdan Imaging, “and we hope that through this new faster, more efficient technology, patient outcomes and survival will be improved.” Cormican (pictured at top), a former physics student at Queens, previously worked with QUBIS to start up Andor Technology, a scientific and industrial imaging company in Belfast.

Financial aspects of the agreement were not disclosed. QUBIS says this is the university’s first equity deal of this kind.

Read more:

*     *     *

2 comments to University, Company to Collaborate on Cancer Imaging